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Hepsin-mediated processing of 
Uromodulin is crucial for Salt-
sensitivity and thick Ascending 
Limb Homeostasis
eric olinger1, Jennifer Lake1, Susan Sheehan2, Guglielmo Schiano1, tomoaki takata  1, 
natsuko tokonami1, Huguette Debaix1, francesco consolato  3, Luca Rampoldi  3, 
Ron Korstanje  2 & olivier Devuyst  1
Uromodulin is a zona pellucida-type protein essentially produced in the thick ascending limb (tAL) 
of the mammalian kidney. it is the most abundant protein in normal urine. Defective uromodulin 
processing is associated with various kidney disorders. the luminal release and subsequent 
polymerization of uromodulin depend on its cleavage mediated by the serine protease hepsin. the 
biological relevance of a proper cleavage of uromodulin remains unknown. Here we combined in vivo 
testing on hepsin-deficient mice, ex vivo analyses on isolated tubules and in vitro studies on tAL cells 
to demonstrate that hepsin influence on uromodulin processing is an important modulator of salt 
transport via the sodium cotransporter NKCC2 in the TAL. At baseline, hepsin-deficient mice accumulate 
uromodulin, along with hyperactivated NKCC2, resulting in a positive sodium balance and a better 
adaptation to water deprivation. in conditions of high salt intake, defective uromodulin processing 
predisposes hepsin-deficient mice to a salt-wasting phenotype, with a decreased salt sensitivity. 
These modifications are associated with intracellular accumulation of uromodulin, endoplasmic 
reticulum-stress and signs of tubular damage. these studies expand the physiological role of hepsin 
and uromodulin and highlight the importance of hepsin-mediated processing of uromodulin for kidney 
tubule homeostasis and salt sensitivity.
Uromodulin, a protein identified by Tamm and Horsfall in 1950, is the most abundant protein excreted in normal 
human urine. The protein is kidney-specific, essentially produced by the tubular cells lining the thick ascending 
limb (TAL) and, to a minor extent, the distal convoluted tubule (DCT) of the nephron. Uromodulin contains 
640 amino acids, with 7 N-glycosylation sites, 4 epidermal growth factor (EGF)-like domains, a zona pellucida 
(ZP) domain and a C-terminal GPI-anchoring site, is released in urine where it forms high-molecular weight 
polymers that constitute the matrix of urine casts1. Multiple lines of evidence support the biological relevance of 
uromodulin, which is encoded by the UMOD gene. Rare missense mutations in UMOD induce aberrant traffick-
ing of mutant uromodulin, leading to endoplasmic reticulum (ER) retention and ER stress that cause autosomal 
dominant tubulointerstitial kidney disease (ADTKD)2,3. On the other hand, genome-wide association studies 
(GWAS) revealed that common variants in the UMOD promoter region, which drive variable expression levels 
of uromodulin, are linked with increased risks of chronic kidney disease, calcium stones and hypertension in the 
general population4–6.
Multiple physiological roles for uromodulin have been proposed, mostly following studies in knockout 
(Umod−/−) mice. These roles reflect the structural features of uromodulin and they include: (i) protection against 
intrarenal and tubular calcium oxalate crystallization (Ca2+-binding EGF-like domains)7; (ii) defense against uri-
nary tract infections mediated by uropathogenic E. coli (high-mannose residues binding to type 1 fimbriae)8; and 
(iii) regulation, in the TAL, of the sodium cotransporter NKCC2 and renal outer medullary potassium channel 
ROMK by the modulation of their activity and surface abundance, thereby affecting avidity for NaCl and ability to 
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concentrate the urine9–12. UMOD variants that are associated with hypertension are known to lead to an increase 
of uromodulin expression and NKCC2 activity in humans13. Whether the physiological role of uromodulin is 
mediated by its cellular processing or apical release into the urine remains unknown.
The luminal release of uromodulin is mediated by a proteolytic cleavage at the C-terminal end of the protein, 
directly downstream of the ZP domain14. ZP domains are essential for the assembly into extracellular polymers 
and are present in many extracellular eukaryotic proteins including egg coat proteins ZP1-3 and α and β-tector-
ins15. Recently, Brunati et al. showed that the transmembrane serine protease hepsin co-localizes with uromodu-
lin in the TAL and is required for the release and subsequent ZP-mediated polymerization of uromodulin. In fact, 
hepsin cleavage removes an external hydrophobic patch (EHP), located downstream of the ZP domain, which is 
normally engaged in an inhibitory interaction with an internal hydrophobic patch (IHP)15,16. Accordingly, Hpn 
KO mice excrete reduced amounts of uromodulin, that is polymerization-incompetent, establishing uromodulin 
as a physiological substrate for hepsin16. The biological consequences of the lack of hepsin, the fate of mispro-
cessed uromodulin, and the potential repercussions for kidney tubular function remain unknown.
Here we combined studies in the hepsin-deficient HpnHlb320/Hlb320 mouse (Hlb320) strain and in isolated TAL 
segments and derived mouse primary TAL (mTAL) cells, which express endogenous uromodulin and hepsin, to 
investigate the biological relevance of the hepsin-mediated processing of uromodulin. In control conditions, the 
functional loss of hepsin leads to cellular accumulation of uromodulin, leading to increased activity of NKCC2 
and defective NaCl handling in vitro and in vivo. In case of high salt exposure, uromodulin excretion dramatically 
increases in wild-type mice but not in Hlb320 mice, in which uromodulin accumulates inside TAL cells, creating 
ER stress and tubular dysfunction. These studies expand the physiological role of hepsin and reveal the impor-
tance of hepsin-mediated processing of uromodulin for salt handling by the kidney.
Results
characterization of hepsin mutation and consequences on urinary uromodulin. The ENU-
induced mouse strain Hlb320 harbors a missense mutation in the 3′ splice site of exon 8 of the Hpn gene encoding 
hepsin17. The original strain was fully backcrossed to the C57BL/6 J strain in order to eliminate random muta-
tions. The HpnHlb320/Hlb320 mice (hereafter referred to as Hlb320) are born at Mendelian ratios, and are viable and 
fertile. Genomic DNA analysis confirmed a thymine to cytosine substitution at the second nucleotide position 
in the 3′ splice site of exon 8 of Hpn (Fig. 1a), with only ∼5% residual Hpn mRNA expression detected in Hlb320 
kidneys by RT-qPCR, no RT-PCR product (exon 8 to stop codon) (Fig. 1b), and no hepsin protein detected in the 
kidney and TAL apical membrane in Hlb320 mice (Fig. 1c). In contrast to Hpn−/− mice, the Hlb320 mice used in 
this study do not display hypothyroidism17, which was shown to reduce kidney expression of uromodulin18. To 
substantiate the effects of hepsin deletion, we analyzed the excretion levels of uromodulin and found it strongly 
decreased in the urine of Hlb320 mice (35.1 ± 5.0% of WT) (Fig. 1d). N-deglycosylation using PNGase F shifted 
the molecular weight of urinary uromodulin from 100 kDa to ~75 kDa in both Hlb320 and WT mice, but revealed 
two distinct uromodulin isoforms in Hlb320 urine (Fig. 1e, red and black arrowhead), most likely reflecting alter-
native uromodulin cleavage products16. Ultracentrifugation-based polymerization assay15, which concentrated 
uromodulin in the pellet fraction in WT urine, resulted in a complete shift of Hlb320 urine uromodulin in the 
supernatant fraction - suggesting incapacity of assembling into polymers (Fig. 1f). Collectively, these results show 
that the loss of hepsin in Hlb320 mice strongly impairs the urinary release of uromodulin, with misprocessing 
(alternative cleavage) and loss of polymerization.
Uromodulin accumulation in vivo and consequences in the kidney. In line with reduced urinary 
levels, the loss of hepsin was reflected by a 3-fold increase of uromodulin in Hlb320 kidneys (Fig. 2a), result-
ing from accumulation in both the membrane and cytosolic fractions and validated by the appropriate markers 
flotillin-1 and GAPDH, respectively (Fig. 2b). Immunofluorescence staining revealed a strong apical enhance-
ment for uromodulin in most of the uromodulin-positive tubules in Hlb320 kidneys (Fig. 2c, left panels, inset) 
with a subset of tubules displaying a broader cytosolic signal (Fig. 2c, left panels, arrow). Co-localization studies 
revealed that cytosolic uromodulin storage was mainly inside the ER and to a lesser extent inside the Golgi appa-
ratus (Fig. 2c, central and right panels). These results show that defective apical cleavage results in the accumu-
lation of uromodulin along the secretory pathway in Hlb320 kidneys. Messenger RNA profiling revealed no 
transcriptional changes in major renal transporters and channels as well as unchanged levels of Umod transcripts 
in Hlb320 kidneys (Fig. 2d). No compensatory upregulation of serine proteases prostasin (Prss8), mucin 1 (Muc1) 
and dipeptidyl-peptidase IV (Dpp4), which are expressed in TAL16, were observed (not shown).
The loss of hepsin in Hlb320 kidneys was reflected by a significant upregulation of total and phosphorylated 
(i.e. active) (Thr96 and Thr101) NKCC2, primarily in the renal cortex, as evidenced by western blotting (Fig. 2e) 
and immunofluorescence (Fig. 2f & Suppl. Fig. S1, Suppl. Fig. S2a, left panels). These changes were TAL-specific 
since, in the DCT, the expression of the total and phosphorylated forms of the Na+, Cl− cotransporter NCC 
were not altered in Hlb320 kidneys, despite a high expression level of hepsin in that segment16. Water chan-
nels expressed in the proximal tubule (AQP1) and collecting duct (AQP2) were also unchanged (Fig. 2e). The 
increased phosphorylation of NKCC2 is most likely driven by increased levels of activated STE20/SPS1-related 
proline-alanine–rich kinase (SPAK) and oxidative stress response 1 kinase (OSR1) as pSPAK/pOSR1 levels were 
markedly higher in NKCC2-positive TAL tubules of Hlb320 mice (Fig. 2g and Suppl. Fig. S2a). In addition, 
uromodulin accumulation at the apical membrane per se might exert a stabilizing role for NKCC2. In line, the 
apical membrane insertion of NKCC2 is reduced and the signal for pNKCC2 is decreased in Umod−/− kidneys 
(Suppl. Fig. S2b). As uromodulin is known to regulate the trafficking of ROMK10, we investigated the expression 
of ROMK in the TAL by performing co-localization studies with uromodulin in Hlb320 and WT mice. As shown 
by a representative immunofluorescence in Suppl. Fig. S3, we could not detect any alteration in ROMK staining 
intensity nor pattern in Hlb320 kidneys.
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Altered TAL function and NaCl balance in Hlb320 mice. At baseline, Hlb320 mice showed a similar 
body weight, water intake, BUN and plasma osmolality levels compared to WT controls (Tables 1 and 2). Hlb320 
mice aged 6 months showed a significantly reduced diuresis with hypernatremia and hyperchloremia (Table 2).
Injection of the loop diuretic furosemide, which blocks NKCC2, led to a major, 2-fold increased response in 
terms of Na+ (and Cl−) excretion in Hlb320 compared to WT mice (Fig. 3a; Table 1). Water deprivation induced 
a numerically larger reduction in urine output in Hlb320 vs. WT mice; this increased ability to conserve water 
completely prevented the rise in plasma osmolality in Hlb320 vs. WT mice (Fig. 3b; Table 1).
We next assessed whether the lack of hepsin affects the metabolism and NKCC2 activity in isolated TAL seg-
ments. Freshly isolated TAL tubules from Hlb320 and WT mice displayed a higher rate of oxygen consumption 
(84.4 ± 4.9 vs. 56.5 ± 4.0 pmoles/min/tubule length, Hlb320 vs. WT, p = 0.0006) (Fig. 3c) and a more pronounced 
drop of oxygen consumption rate after application of the loop diuretic bumetanide (−14.9 ± 2.0 vs. −8.5 ± 1.8 
pmoles/min/tubule length, Hlb320 vs. WT, p = 0.042) (Fig. 3c).
Figure 1. Characterization of hepsin mutation and consequences on urinary uromodulin. (a) Antisense strand 
electropherogram obtained by Sanger sequencing of genomic DNA extracted from HpnHlb320/Hlb320 (Hlb320) and 
HpnWT/WT (WT) kidney. Above the chromatograph is shown a schematic representation of the corresponding 
region of Hpn gene with the red dot highlighting the transition of A to G in the second base pair in the 3′ splice 
site of exon 8 (affecting the splicing donor site in intron 8), corresponding to a T to C transition on the sense 
strand. (b) Transcript level of Hpn, assessed by RT-qPCR on total kidney extracts from Hlb320 and WT mice 
using primers directed against exons 8 and 9. A normalization factor based on 6 different housekeeping genes 
was used. N = 4; bars indicate mean ± s.e.m.; ****p ≤ 0.0001 (Unpaired two-tailed t test). Inset: Hpn 3′ RT-PCR 
amplification product (exon 8 to stop codon) from Hlb320 and WT kidneys. Predicted size of amplification 
product is 740 base pairs. Gapdh is used as a loading control. (c) Upper panels: Immunofluorescence analysis 
for hepsin (red) in mouse kidney sections from Hlb320 and WT mice. Scale bar: 50 µm. Lower panels: High 
magnification immunofluorescence analysis for hepsin (red) and uromodulin (green) in mouse kidney sections 
from Hlb320 and WT mice. Scale bar: 10 µm; G, glomerulus. (d) Western blot analysis of urinary uromodulin 
excretion in Hlb320 and WT mice (loading according to urinary creatinine). Densitometric analysis shown 
next to the blot. Bars indicate mean ± s.e.m.; ***p ≤ 0.001 (Unpaired two-tailed t test). (e) Representative 
western blot analysis of urinary uromodulin with or without peptide-N-glycosidase F (PNGase F), which 
removes N-linked oligosaccharides from glycoproteins. Red and black arrowheads indicate longer and shorter 
isoforms, respectively. The equivalent of 0.5 µg and 1 µg of creatinine were loaded for the WT and Hlb320 
urine, respectively. (f) Representative western blot analysis of urinary uromodulin isolated from the pellet 
(P) or the supernatant (S) fractions after polymerization assay performed on urine from Hlb320 or WT mice. 
Densitometric analysis of pellet/supernatant uromodulin indicating uromodulin’s propensity to engage in 
polymeric structures is shown next to the blot. N = 3; bars indicate mean ± s.e.m.; *p ≤ 0.05 (Unpaired two-
tailed t test). Uncropped image of blots can be found in Supplementary Figure S8.
4Scientific RepoRtS |         (2019) 9:12287  | https://doi.org/10.1038/s41598-019-48300-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
These data demonstrate that the lack of hepsin leads to NKCC2 hyperactivation in the TAL of Hlb320 kidneys, 
with major alterations in salt and water handling in vivo.
Because of the protective effect of uromodulin against uropathogenic E. coli8, we also tested the susceptibility 
of Hlb320 mice to bladder colonization by transurethral inoculation of type-1 fimbriated uropathogenic E. coli. 
We could not detect any differences in bladder bacterial titers compared to WT mice (5.2 × 106 ± 4.8 × 105 CFU/
gBladder vs. 4.4 × 106 ± 1.2 × 106 CFU/gBladder, N = 7–9, p = 0.46) (Suppl. Fig. S4).
Figure 2. Uromodulin accumulation in vivo and consequences in the kidney. (a) Western blot analysis of 
total kidney uromodulin from Hlb320 and WT mice. β-actin is blotted as a loading control and densitometric 
analysis is shown next to the blot. Bars indicate mean ± s.e.m.; ***p ≤ 0.001 (Unpaired two-tailed t test).
(b) Upper panels: Western blot analysis for uromodulin on kidney fractions enriched in large membranes/
plasma membrane (“membrane fraction”) from Hlb320 and WT mice. Integral plasma membrane protein 
flotillin-1 and GAPDH are blotted as positive and negative controls, respectively. Densitometric analysis with 
normalization to flotillin-1 is shown next to the blot. Bars indicate mean ± s.e.m.; *p ≤ 0.05 (Unpaired two-
tailed t test). Lower panels: Western blot analysis for uromodulin on kidney fractions enriched in cytoplasmic 
proteins/small vesicles (“cytosolic fraction”) from Hlb320 and WT mice. Cytosolic protein GAPDH and 
flotillin-1 are blotted as positive and negative controls, respectively. Densitometric analysis with normalization 
to GAPDH is shown next to the blot. Bars indicate mean ± s.e.m.; **p ≤ 0.01 (Unpaired two-tailed t test). (c) 
Representative immunofluorescence analysis for uromodulin (green) and ER chaperone calnexin (red) and 
Golgi protein GM130 (red) on kidney sections from Hlb320 and WT mice, as indicated. Nuclei are stained 
in blue with DAPI. Scale bar: 50 µm and 25 µm for co-localization studies; G, glomerulus. (d) Transcript 
levels of major renal transporters and channels as assessed by RT-qPCR on total kidney extracts from Hlb320 
mice and WT mice. A normalization factor based on 6 different housekeeping genes was used and results are 
expressed relative to WT expression (red dotted line). N = 4. Bars indicate mean ± s.e.m. Lrp2, megalin; Aqp1, 
aquaporin-1; Slc12a1a, NKCC2A; Slc12a1b, NKCC2B; Slc12a1f, NKCC2F; Kcnj1, ROMK; Umod, uromodulin; 
Slc12a3, NCC; Aqp2, aquaporin-2; Scnn1b, β-ENaC; Scnn1c, γ-ENaC. (e) Western blot analysis in total kidney 
lysates from Hlb320 and WT mice. A representative β-actin blot is shown as loading control. Densitometric 
analysis (relative to WT kidneys: red dotted line) is shown below the blots. Bars indicate mean ± s.e.m.; 
*p ≤ 0.05; ***p ≤ 0.001 (Unpaired two-tailed t test). (f) Representative immunofluorescence analysis for 
uromodulin (green) and phosphorylated NKCC2 (at position Thr96, red) in kidney sections from Hlb320 and 
WT mice. Nuclei are stained in blue with DAPI. Scale bar: 50 µm; G, glomerulus. (g) Western blot analysis for 
phosphorylated SPAK (Ser373)/phosphorylated OSR1 (Ser325) and total SPAK in total kidney lysates from 
Hlb320 and WT mice. β-actin is blotted as a loading control. Densitometric analysis reports levels normalized 
to β-actin in Hlb320 kidneys relative to WT kidneys. Bars indicate average ± s.e.m.; **p ≤ 0.01, ****p ≤ 0.0001 
(Unpaired two-tailed t test). Uncropped image of blots can be found in Supplementary Figure S8.
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Altered uromodulin processing and NKCC2 activation in Hlb320 mTAL cells. We next used the 
mTAL primary cell system, with conserved processing and secretion of endogenous uromodulin19 to investi-
gate the cell-autonomous consequences of hepsin deletion. Compared to mTAL cells derived from WT kidneys, 
mTAL cells from Hlb320 kidneys completely lacked uromodulin polymers on the apical surface; displayed api-
cal membrane and cytosol/ER accumulation of uromodulin; and released considerably less uromodulin in the 
apical compartment (Fig. 4a–d). Reduced secretion of polymerization-incompetent uromodulin could also be 
shown in WT mTAL cells transduced with shRNA directed against Hpn mRNA, leading to knockdown of hepsin 
(Suppl. Fig. S5). Of note, mTAL cells derived from Hlb320 mice display robust expression levels of Umod mRNA 
(160 ± 24% of WT mTAL cells, p = 0.10, data not shown). Hlb320 mTAL cells displayed increased levels of phos-
phorylated NKCC2 by western blotting (Fig. 4e) and by immunofluorescence (Fig. 4f), translating into a signif-
icantly increased bumetanide-inhibitable transepithelial voltage (Fig. 4g). Furthermore, in contrast to WT cells, 
Hlb320 mTAL cells were unable to increase their transepithelial voltage when treated with basolateral ddAVP, a 
Baseline Furosemide Water deprivation
WT Hlb320 n WT Hlb320 n WT Hlb320 n
Body weight (BW; g) 23.2 ± 0.5 22.6 ± 0.6 5/5
Daily Water Intake (mL/gBW) 0.17 ± 0.01 0.15 ± 0.01 5/5
Diuresis (µL/min*gBW) 0.0204 ± 0.0011 0.024 ± 0.002 5/5 0.062 ± 0.013† 0.066 ± 0.018 5/5 0.008 ± 0.002 †† 0.005 ± 0.002 †† 5/5
Urinary Na+ (nmol/ng creat) 0.19 ± 0.01 0.23 ± 0.01** 5/5 1.18 ± 0.21†† 3.02 ± 0.6*,†† 5/5 0.28 ± 0.04 0.23 ± 0.04 5/3‡
Urinary Cl− (nmol/ng creat) 0.33 ± 0.01 0.32 ± 0.01 5/5 1.29 ± 0.23† 3.25 ± 0.71*,† 5/5 0.41 ± 0.06 0.31 ± 0.04 5/3‡
Urinary Osmo (mOsm/KgH2O) 3914 ± 189 3560 ± 194 5/5 665 ± 103†††† 500 ± 69†††† 5/5 6380 ± 906† 5865 ± 545 5/3‡
Urinary Creatinine (mg/dL) 124 ± 8.1 118 ± 5.4 5/5 15.0 ± 3.9†††† 7.1 ± 2.5†††† 5/5 158 ± 10.4† 190 ± 17.4†† 5/3‡
Blood urea nitrogen (mg/dL) 23.3 ± 1.0 23.0 ± 1.0 6/5
Plasma Na + (mmol/L) 154 ± 0.8 153 ± 0.7 6/5 / /
Plasma Cl− (mmol/L) 114 ± 0.8 116 ± 0.7 6/5 131 ± 1.8††† 126 ± 0.6*,††† 4/5
Plasma Osmo (mOsm/KgH2O) 325 ± 1 320 ± 3 6/4 358 ± 6†† 330 ± 1** 6/4
Table 1. Physiological parameters in 2-month-old Hlb320 and WT mice (Baseline vs. furosemide vs. water 
deprivation). Values represent means ± s.e.m.; n: number of mice; ‡, urine volume insufficient for analyses in 
2/5 Hlb320 mice during water deprivation. Unpaired two-tailed t test: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001, WT 
vs. Hlb320. Paired two-tailed t test: †p ≤ 0.05; ††p ≤ 0.01; †††p ≤ 0.001; ††††p ≤ 0.0001, Intervention vs. baseline. 
Furosemide, 0.01 mg/gBW in 0.9% saline, IP; Water deprivation during 24 h; WT, C57BL/6J-HpnWT/WT; Hlb320, 
C57BL/6J-HpnHlb320/Hlb320.
Control NaCl loading
WT Hlb320 n WT Hlb320 n
Body weight (BW; g) 31.9 ± 0.8 30.7 ± 1.1 5/5 32.2 ± 1.2 24.6 ± 1.4**,$$ 6/5
Daily Water Intake (mL/gBW) 0.15 ± 0.02 0.12 ± 0.01 5/5 0.57 ± 0.18 3.28 ± 0.26****,$$$$ 6/5
Systolic blood pressure (mmHg) 112.9 ± 2.8 106.4 ± 2.9 6/9 125.7 ± 4.2†† 101.5 ± 2.5*** 6/9
Diuresis (µL/min*gBW) 0.046 ± 0.006 0.021 ± 0.002** 5/5 0.201 ± 0.049$ 1.632 ± 0.144****,$$$$ 6/5
Urinary Na+ (nmol/ng creat) 0.20 ± 0.02 0.21 ± 0.02 5/5 2.24 ± 0.34$$$ 27.29 ± 3.79****,$$$ 6/5
FeNa+ (%) 0.10 ± 0.03 0.08 ± 0.01 5/5 1.04 ± 0.34$ 9.89 ± 1.64***,$$$ 5/4
Urinary Cl− (nmol/ng creat) 0.39 ± 0.04 0.31 ± 0.03 5/5 2.26 ± 0.36$$ 26.00 ± 3.48****,$$$$ 6/5
Urinary Ca2+ (nmol/ng creat) 0.0029 ± 0.0008 0.0015 ± 0.0004 5/5 0.0060 ± 0.0012 0.0893 ± 0.0122***,$$$$ 5/5
Urinary Mg2+ (nmol/ng creat) 0.144 ± 0.008 0.129 ± 0.006 5/5 0.118 ± 0.016 0.283 ± 0.031***,$$ 6/5
Urinary Osmo (mOsm/KgH2O) 1524 ± 212 2000 ± 273 5/5 1204 ± 90 747 ± 20***,$$ 6/5
Urinary Creatinine (mg/dL) 41.0 ± 9.3 53.5 ± 7.4 5/5 18.0 ± 2.3$ 1.4 ± 0.2***,$$$ 6/5
Blood urea nitrogen (mg/dL) 25.3 ± 1.3 21.3 ± 0.6* 5/5 21.5 ± 1.8 13.2 ± 2.1*,$$ 6/5
Creatinine clearance (mL/min*gBW) 0.029 ± 0.007 0.020 ± 0.005 5/5 0.046 ± 0.013 0.032 ± 0.007 4/4
Plasma Na+ (mmol/L) 147 ± 0.6 152 ± 0.6*** 5/5 151 ± 2.2 182 ± 4.6***,$$$ 6/4
Plasma Cl− (mmol/L) 109 ± 0.4 113 ± 0.7** 5/5 112 ± 2.2 140 ± 4.2***,$$$ 6/5
Plasma Ca2+ (mmol/L) 2.29 ± 0.02 2.27 ± 0.02 5/5 2.43 ± 0.04$ 2.05 ± 0.04****,$$ 6/5
Plasma Mg2+ (mg/dL) 2.61 ± 0.08 2.69 ± 0.04 5/5 2.96 ± 0.13 2.29 ± 0.28* 6/5
Plasma Osmo (mOsm/KgH2O) 333 ± 3 341 ± 1 5/5 339 ± 1 377 ± 9**,$$ 6/5
Table 2. Physiological parameters in 6-month-old Hlb320 and WT mice (Control conditions vs. NaCl 
loading). Values represent means ± s.e.m.; n: number of mice. Unpaired two-tailed t test: *p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001; ****p ≤ 0.0001, WT vs. Hlb320; $$p ≤ 0.01; $$$p ≤ 0.001; $$$$p ≤ 0.0001, Intervention vs. baseline 
Paired two-tailed t test: ††p ≤ 0.01, Intervention vs. baseline. NaCl loading, 2% NaCl in drinking water for 2 
months; WT, C57BL/6J-HpnWT/WT; Hlb320, C57BL/6J-HpnHlb320/Hlb320.
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potent stimulator of NKCC2 phosphorylation and apical membrane insertion20, suggesting maximal recruitment 
of NKCC2 at baseline in these cells (Fig. 4h). Taken together, these studies in primary mTAL cells confirm all the 
changes observed in the Hlb320 mice and substantiate a cell-autonomous interplay between hepsin-mediated 
uromodulin processing and regulation of NKCC2 activity.
NaCl loading drives uromodulin accumulation and tubular damage in Hlb320 mice. In view of 
the established link between dietary NaCl and expression of uromodulin21, we challenged WT and Hlb320 mice 
with a NaCl loading protocol (2% NaCl in drinking water) for 2 months. In contrast to WT mice, which showed 
a marked increase in levels of urinary uromodulin starting at day 7 and lasting 1 month, Hlb320 mice showed 
no increase (and even a decrease at day 7) in the urinary levels of uromodulin after NaCl loading (Fig. 5a). As a 
consequence of this defective urinary release, the NaCl loading led to a massive further increase of uromodulin 
accumulation in the kidneys of Hlb320 mice after 2 months, which was not observed in WT mice (Fig. 5b). These 
dramatic changes in uromodulin accumulation induced by NaCl loading were confirmed in the TAL profiles from 
Hlb320 vs. WT mice (Fig. 5c). Because of the ER-accumulation of uromodulin in Hlb320 mice, we investigated 
the levels of ER chaperone and ER stress marker GRP78 and detected an upregulation in NaCl loaded Hlb320 
kidneys (Fig. 5d), emanating from uromodulin-positive TAL tubules (Fig. 5e). Neutrophil gelatinase-associated 
lipocalin (NGAL) is a biomarker of renal tubule injury that is selectively expressed after ER stress and is causally 
linked to progression of renal disease22,23. The transcript levels of NGAL (encoded by Lcn2) were strongly upreg-
ulated in NaCl loaded Hlb320 vs. WT kidneys (Fig. 5f) with a parallel increase in urinary (Fig. 5g) and kidney 
(Fig. 5h) levels of NGAL. Histological analysis of PAS-stained kidney sections reveals distal tubular damage with 
massively dilated tubule profiles in salt-loaded Hlb320 mice, but not in Hlb320 mice under control conditions or 
in NaCl loaded WT mice (Fig. 5i).
Salt-losing (Bartter-like) phenotype in NaCl loaded Hlb320 mice. After 2 months of NaCl loading, 
Hlb320 mice developed a severe renal phenotype that resembles Bartter syndrome, including massive polyuria 
with NaCl, Ca2+ and Mg2+ wasting, decline in body weight with a concomitant rise in plasma osmolality, hypoc-
alcemia and hypomagnesemia. Glomerular filtration was not deteriorated as shown by creatinine clearance and 
BUN levels (reduced BUN reflecting most probably muscle wasting) (Fig. 6a & Table 2) and plasma potassium 
Figure 3. Altered TAL function and NaCl balance in Hlb320 mice. (a) Furosemide test: Percentage (%) of 
change in diuresis (left panel, µL/min*gBW) and natriuria (right panel, nmol/ng creat) during 4 hours following 
an intraperitoneal injection of furosemide (0.01 mg/g of body weight) in Hlb320 mice (red) and WT mice 
(black). Bars indicate mean ± s.e.m. Each dot represents a mouse; Unpaired two-tailed t test: *p ≤ 0.05. (b) 
Water deprivation test: Diuresis (µL/min*gBW) and plasma osmolality (mOsm/KgH2O) at baseline and during/
after a 24-hour period of water deprivation in Hlb320 mice (red) and WT mice (black). Each dot represents 
a mouse; Unpaired two-tailed t test: **p ≤ 0.01; Paired two-tailed t test: ††p ≤ 0.01. (c) Oxygen consumption 
rate (OCR, pmoles/min/tubule length) in freshly isolated TALs from Hlb320 (red) and WT (grey) mice, as 
assessed using the Seahorse technology© at baseline (left) and its reduction after bumetanide application 
(100 µM) (right). Each dot represents a pooled collection of ±70 TALs. Bars indicate mean ± s.e.m.; *p ≤ 0.05; 
***p ≤ 0.001 (Unpaired two-tailed t test).
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levels were unchanged (4.1 ± 0.1 mmol/L in Hlb320 vs. 4.2 ± 0.1 mmol/L in WT mice, n = 4, after 1 month of NaCl 
loading). The link between ER stress and TAL dysfunction was supported by experiments on mTAL cells using 
tunicamycin, a potent inducer of ER stress by blocking N-linked glycosylation. Tunicamycin treatment increased 
NGAL expression, reduced the expression of total NKCC2 (and to a lesser extend of phosphorylated NKCC2) and 
led to a drop in the transepithelial voltage and the vectorial Ca2+ transport in mTAL cells (Suppl. Fig. S6).
Figure 4. Altered uromodulin processing and NKCC2 activation in Hlb320 mTAL cells. (a) Representative 
immunofluorescence analysis for uromodulin (green) in permeabilized mTAL cells derived from Hlb320 
and WT mice. A view of the apical cell surface and through the nuclear plan (intracellular), with the z-plan 
reconstructions, are shown. Nuclei are stained in blue with DAPI. Scale bar: 25 µm. (b) Representative output 
picture and result of polymer number per field quantification using ImageJ Ridge Detection in mTAL cells 
from Hlb320 and WT mice. N = 15 fields from 3 mTAL cultures. Scale bar: 50 µm; bars indicate mean ± s.e.m.; 
****p ≤ 0.0001 (Unpaired two-tailed t test). (c) Representative immunofluorescence analysis for uromodulin 
(green) and ER chaperone calnexin (red) in permeabilized mTAL cells derived from Hlb320 and WT mice. 
Inset: zoom on single cell. Nuclei are stained in blue with DAPI. Scale bar: 50 µm. (d) Representative western 
blot analysis of uromodulin secreted in the apical compartment of mTAL cells derived from Hlb320 and 
WT mice. Same apical volumes were loaded in each lane. Densitometric analysis is shown next to the blot. 
Bars indicate mean ± s.e.m.; ****p ≤ 0.0001 (Unpaired two-tailed t test). (e) Western blot analysis for 
phosphorylated (Thr96 and Thr101) and total NKCC2 in mTAL cells from Hlb320 and WT mice. β-actin 
is shown as a loading control. Each lane represents a different mTAL cell culture. Densitometric analysis 
(relative to WT) is shown next to the blots. Bars indicate mean ± s.e.m.; **p ≤ 0.01 (Unpaired two-tailed t 
test). (f) Representative immunofluorescence analysis for phosphorylated NKCC2 (at position Thr96, red) in 
permeabilized mTAL cells derived from Hlb320 and WT mice. Z-plan reconstructions are shown on the picture 
borders. Nuclei are stained in blue with DAPI. Scale bar: 25 µm. (g) Transepithelial voltage (Vte, mV) recordings 
using a chopstick electrode on mTAL cells derived from Hlb320 (red), WT (black) mice and WT cultures after 
application of apical bumetanide (100 µM; white). Each dot represents a filter of primary TAL cells. Bars indicate 
mean ± s.e.m.; ****p ≤ 0.0001 (Unpaired two-tailed t test). (h) Evolution of transepithelial voltage (Vte, mV) 
after basolateral ddAVP application (0.1 µM) in mTAL cells derived from Hlb320 (red) or WT (black) mice. 
Each dot represents a mTAL cell culture. Bars indicate mean ± s.e.m.; *p ≤ 0.05; **p ≤ 0.01 (Unpaired two-
tailed t test). The RT-PCR amplification product for Avpr2 is shown for Hlb320 and WT mTAL cultures. Gapdh 
is shown as a loading control. Uncropped image of blots can be found in Supplementary Figure S8.
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The changes in tubular function were reflected by differences in blood pressure as assessed by tail cuff record-
ings over the period of 2 months. In accordance with previous reports11, WT mice increased their systolic blood 
pressure (SBP) over the course of the 2% NaCl loading. In sharp contrast, Hlb320 mice showed no increase in SBP 
after 1 and 2 months of NaCl loading, most likely reflecting the observed NaCl wasting and the dysfunction of the 
TAL segment (Fig. 6b, left panel & Suppl. Fig. S7). These alterations in renal NaCl avidity were reflected by a shift 
in the relationship between Na+ intakes with SBP, when comparing Hlb320 vs. WT mice (Fig. 6b, right panel). 
In a subset of mice, we analyzed the phosphorylation ratio of NKCC2 after 1 month of 2% NaCl loading, since 
the difference in SBP response became apparent at that timepoint. A defective phosphorylation level of NKCC2 
Figure 5. NaCl loading drives uromodulin accumulation and tubular damage in Hlb320 mice. (a) 
Representative western blot analysis for urinary uromodulin excreted in Hlb320 and WT mice at baseline 
(BL) and at different time points of an oral 2% NaCl loading protocol. Western blot loading is normalized 
to urinary creatinine to account for urine dilution and cropped images are shown for ease of representation. 
The densitometric analysis indicates relative changes of urinary uromodulin levels at indicated time points as 
compared to the baseline values for that same mouse for samples that have been loaded on the same gel. N = at 
least 3. Bars indicate mean ± s.e.m.; *p ≤ 0.05; **p ≤ 0.01 (Paired two-tailed t test, values at indicated time point 
vs. baseline values). (b) Western blot analysis for kidney uromodulin levels in Hlb320 and WT mice under 
control conditions and after 2 months of NaCl loading. β-actin is shown as a loading control. Densitometric 
analysis relative to control WT. Bars indicate mean ± s.e.m.; *p ≤ 0.05; ***p ≤ 0.001; ****p ≤ 0.0001 (Unpaired 
two-tailed t test). (c) Representative immunofluorescent analysis for uromodulin (green) on kidney sections 
from Hlb320 and WT mice at control conditions and after 2 months of NaCl loading, as indicated. Scale bar: 
50 µm; G, glomerulus. (d) Western blot analysis of kidney GRP78 levels in Hlb320 and WT mice under control 
conditions and after 2 months of NaCl loading. β-actin is shown as a loading control. (e) Representative 
immunofluorescent analysis for uromodulin (green) and ER-stress marker GRP78 (red) on kidney sections 
from NaCl loaded Hlb320 mice. Scale bar: 50 µm. (f) Transcript levels of Lcn2 (NGAL), assessed by RT-
qPCR on total kidney extracts from Hlb320 and WT mice at control conditions and after 2 months of NaCl 
loading, as indicated. A normalization factor based on 6 different housekeeping genes was used and levels 
are expressed relative to control WT. N = at least 4; bars indicate mean ± s.e.m.; *p ≤ 0.05 (Unpaired two-
tailed t test). (g) ELISA for NGAL (ng/mg creatinine, log 10 scale) in the urine of Hlb320 and WT mice under 
control conditions and after 2 months of NaCl loading, as indicated. Each dot represents urine collected from 
a different mouse. Bars indicate mean ± s.e.m.; *p ≤ 0.05 (Unpaired two-tailed t test). (h) Western blot analysis 
of kidney NGAL levels in Hlb320 and WT mice under control conditions and after 2 months of NaCl loading, 
as indicated. β-actin is shown as a loading control. Densitometric analysis relative to control WT. Bars indicate 
mean ± s.e.m.; **p ≤ 0.01 (Unpaired two-tailed t test). (i) Representative histological analysis (Periodic acid-
Schiff) of the renal cortex of Hlb320 and WT mice at control conditions and after 2 months of NaCl loading, as 
indicated. Scale bar: 100 µm. Uncropped image of blots can be found in Supplementary Figure S8.
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with an inverted phospho/total NKCC2 ratio was detected specifically in the NaCl loaded Hlb320 mice (data 
not shown). Collectively, these results indicate that the hepsin-dependent processing of uromodulin is critical to 
regulate the NaCl-handling capacity of the TAL segment exposed to high salt intake. In such conditions, defective 
hepsin leads to a major accumulation of uromodulin causing ER stress and NGAL expression, with TAL dysfunc-
tion and abnormal regulation of NaCl handling and blood pressure.
Discussion
Our studies show, for the first time, that the hepsin-mediated release and polymerization of uromodulin modu-
lates the salt transporting activity of TAL cells in vivo and in vitro. The intracellular accumulation of uromodulin 
in hepsin-deficient mice and cells drives the hyperactivation of the cotransporter NKCC2, reflected by signif-
icant modifications of the response to pharmacological and physiological testing. Exposure to NaCl triggered 
hepsin-mediated urinary uromodulin release in control mice, contrasting with intracellular accumulation of 
uromodulin causing epithelial dysfunction and defective blood pressure regulation in hepsin-deficient mice. 
Collectively these data show that the processing of uromodulin in the kidney tubule is crucial for salt handling 
and blood pressure regulation.
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Figure 6. Bartter-like phenotype in NaCl loaded Hlb320 mice. (a) Evolution of physiological parameters 
related to kidney function in Hlb320 (red) and WT (black) mice in control conditions and after NaCl loading, 
as indicated. Each dot represents a mouse. Bars indicate mean ± s.e.m.; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; 
****p ≤ 0.0001 (Unpaired two-tailed t test). (b) Left panel: Systolic blood pressure (SBP) averages as assessed 
by tail cuff measurements on the same mice during 2 months. Each single dot represents an average of 3–5 
consecutive daily SBP recordings in Hlb320 (red) and WT (black) mice at control conditions and at different 
reporting periods after NaCl loading, as indicated. Bars indicate mean ± s.e.m.; ***p ≤ 0.001 (Unpaired two-
tailed t test); ††p ≤ 0.01 (Paired two-tailed t test: SBP at 2 months of NaCl loading versus baseline). Right panel: 
Pressure-natriuresis relationship obtained by plotting Na+ excretion (µmol/24 h) against SBP for Hlb320 (red) 
and WT (black) mice at control conditions and after NaCl loading, as indicated. Error bars indicate means ± s.d.
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We provide the first report of a kidney phenotype linked to the functional loss of the serine protease hepsin. 
Mice lacking hepsin display increased levels of functionally active (phosphorylated) NKCC2 at baseline, with a 
positive NaCl balance and an increased ability to conserve water during testing. In light of previous studies in 
uromodulin-deficient and -overexpressing mice, NKCC2 hyperactivation in Hlb320 mice is most likely driven 
by the misprocessing and cellular accumulation of uromodulin9,13. In fact, Hlb320 and Umod−/− mice present a 
mirror phenotype with respect to water handling, a feature that could reflect the reduced function of NKCC2 
in the former and the hyperactivation of NKCC2 in the latter. The observed phenotype of the Hlb320 mice is 
biologically meaningful: NKCC2 is selectively active in the TAL segment that expresses uromodulin and it is a 
crucial player in blood pressure control as demonstrated by the effects of genetic (Type 1 Bartter syndrome) and 
pharmacological (loop diuretics) inhibition24.
NKCC2 is regulated at the level of its trafficking and phosphorylation, with an expanding number of molec-
ular mechanisms involved. These include the highly homologous SPAK and OSR1 kinases, which themselves 
are under the control of upstream WNK kinases25. The levels of uromodulin expression have been shown to 
correlate directly with the activity of NKCC2, most likely through regulation of intracellular chloride levels and 
modulation of the chloride sensitive WNK-SPAK/OSR1 pathway9,13. Activity of this pathway is increased in the 
kidneys of Hlb320 mice, along with an increased phosphorylation of NKCC2. The mechanism by which uro-
modulin modulates SPAK/OSR1 activity could involve potentialization of with-no-lysine kinase (WNK) activity, 
as previously suggested9. The facts that (i) soluble uromodulin (truncated at the GPI-anchoring site) is unable 
to activate NKCC213; (ii) NKCC2 and uromodulin are distributed in close spatial vicinity9; and (iii) uromod-
ulin and NKCC2 are sharing lipid raft localization26 raise the possibility that uromodulin acts as a scaffold for 
WNK-SPAK/OSR1-dependent activation of NKCC2. The data presented here extend the role of uromodulin in 
NKCC2 activation, by showing that the dynamics of uromodulin processing modulates NKCC2 activity. Of note, 
the polymerization of uromodulin is not required for the NKCC2 regulatory effect. The fact that total NKCC2 
levels are increased in Hlb320 kidneys suggests an additional effect of the lipid raft-associated uromodulin on the 
turnover of NKCC2, similar to what has been shown for MAL/VIP1727.
The complete absence of endogenous uromodulin polymers in primary TAL cells derived from 
hepsin-deficient mice confirm the requirement of this protease for uromodulin polymerization. The physiological 
relevance of uromodulin polymerization and matrix formation is still unclear1. Under specific ionic conditions, 
uromodulin polymers form a water-impermeable matrix, which could be important to ensure the water imper-
meability of the TAL segment28. However, Hlb320 mice completely lack urinary uromodulin polymers and still 
they display an increased capacity of water retention. The fact that complete absence of uromodulin in Umod KO 
mice leads to a urinary concentrating defect29, that is not encountered in Hlb320 mice, might indicate that small 
quantities of monomeric uromodulin in the lumen are sufficient to assure water impermeability. Alternatively, the 
activation of NKCC2 in the TAL, resulting from the accumulation of uromodulin in Hlb320 mice, may increase 
the medullary osmotic gradient and, in turn, drive a higher urinary concentrating ability. The reasonable amounts 
of glycosylated uromodulin still secreted by the Hlb320 mice may also explain their intact protection against uro-
pathogenic E. coli30. Contrary to 6 month-old Hlb320 mice, which show a positive NaCl balance, young Hlb320 
mice display a trend for Na+ wasting in urine. This observation suggests that the phenotype develops with aging 
and may reflect a progressive accumulation of uromodulin in TAL cells. Because the uromodulin processing 
machinery is conserved in primary mTAL cells, monolayers derived from WT and Hlb320 mice represent a valu-
able tool for future mechanistically investigations regarding the impact of GPI-anchored uromodulin on cellular 
homeostasis.
Several lines of evidence point towards an interplay between uromodulin, salt, and blood pressure. Trudu 
et al.13 showed that hypertensive individuals homozygous for an UMOD promoter variant driving higher uro-
modulin expression levels display an exaggerated response to furosemide when compared to individuals har-
boring the UMOD genotype associated with lower levels of uromodulin expression. This observation strongly 
suggests that UMOD promoter variants are contributing to the regulation of NKCC2 activity and NaCl transport, 
via their influence on uromodulin expression. In rats, high dietary NaCl intake increased uromodulin mRNA 
and protein levels in kidneys21. In humans, urinary uromodulin levels positively correlated with NaCl intake6,31. 
Furthermore, subjects with the highest uromodulin levels after high NaCl diet were also more prone to develop 
salt-sensitive hypertension, suggesting a higher salt-sensitivity of the TAL31. Based on these observations, we 
tested the effect of NaCl exposure on the hepsin-mediated processing of uromodulin. Our experiments reveal 
that the transient increase in uromodulin excretion induced by NaCl exposure, observed in control mice, is solely 
mediated by hepsin - without alternative cellular pathways to excrete uromodulin or to reduce its production. In 
turn, the defective processing of uromodulin in the Hlb320 mice leads to its accumulation in the ER, leading to 
ER stress (GRP78) and renal tubular injury (NGAL, histology). These changes are paralleled by a severe tubular 
dysfunction: after 2 months of NaCl loading, Hlb320 mice developed NaCl wasting and a loss of NaCl-sensitivity 
evidenced by a shift in the relationship between Na+ intakes with systolic blood pressure. Hepsin-mediated pro-
cessing of uromodulin is thus critical to sustain the NaCl-handling capacity of the TAL and, more generally, the 
role of the kidney tubule in blood pressure regulation.
It should be pointed that NaCl loading caused uncompensated polyuria with weight loss and severe hyperna-
tremia in the Hlb320 mice. The increase in plasma sodium levels was reminiscent of that observed in Avpr2Y/− 
pups with nephrogenic diabetes insipidus or in Slc12a1−/− pups with Bartter syndrome type 132,33. Of note, the 
Bartter-like phenotype with uncompensated polyuria and hypernatremia was not observed after 1 month of NaCl 
loading in Hlb320 mice (except for reduced systolic blood pressure), suggesting a time-dependent mechanism 
compatible with progressive ER accumulation of uromodulin.
Finally, these studies in hepsin-deficient systems emphasize the vulnerability of the TAL, a kidney tubule 
segment that is constantly producing, at high level, a complex protein requiring a challenging ER quality control, 
while being involved in highly regulated transport processes involved in NaCl and divalent cation handling. It 
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should be noted that deficient cleavage of uromodulin, which is supposed to take place at the apical membrane16, 
leads not only to the expected uromodulin accumulation at the apical membrane but also to an engorgement 
of the secretory pathway, and particularly the ER, with the protein. Due to its complex tertiary structure (24 
disulfide bridges), uromodulin is challenging in terms of ER proteostasis as reflected by a particularly long ER 
residency34. The delicate balance between ER proteostasis and ER stress is illustrated here, with robust increase in 
GRP78 and NGAL markers and dysfunction of TAL cells of the Hlb320 mice exposed to NaCl load, mimicking 
what is observed in the ER-storage disease caused by mutated uromodulin3.
Materials and Methods
Mouse lines. Hlb320 mice were generated at The Jackson Laboratory as part of an ENU mutagenesis pro-
gram as previously described17. The Hlb320 strain was backcrossed for >10 generations to the C57BL/6J strain 
before the experiments. The nucleotide missense change was confirmed by Sanger sequencing using an Applied 
Biosystems 3730 DNA Analyzer (Applied Biosystems, Foster City, CA). All animals were housed in temperature- 
and humidity-controlled pathogen-free facility with free access to acidified water and a standard rodent chow diet 
(5kK2 LabDiet, Brentwood, MO). Animal procedures were carried out at The Jackson Laboratory, Bar Harbor, ME 
and at the University of Zurich, Zurich, Switzerland according to protocols approved by The Jackson Laboratory’s 
Animal Care and Use Committee and the Swiss Cantonal Veterinary Authority (103/2014), respectively.
treatment protocols, plasma and urine collection, biochemical analysis. Furosemide test and 
water deprivation were performed on 8 weeks-old male Hlb320 and WT mice. Furosemide testing was performed 
by administering a single intraperitoneal injection of furosemide (0.01 mg/g of body weight in 0.9% saline; 
Sigma-Aldrich, Saint-Louis, MO) with subsequent urine collection during 4 hours. Mice were deprived of water 
for 24 h, urine was collected during this period and mice were sacrificed thereafter. 16 weeks-old male Hlb320 
and WT mice were evaluated at baseline and then administered 2% NaCl in drinking water for 4 or 8 weeks, and 
sacrificed at the end of the NaCl loading period. Urine was collected using individual metabolic cages (UNO 
Roestvastaal BV, Zevenaar, The Netherlands) after appropriate training and in a light- and temperature-controlled 
room. Blood was sampled in the sublingual artery or by cardiac puncture at the time of sacrifice. Blood was cen-
trifuged at 2000 g for 15 minutes at 4 °C in heparin-coated tubes (Sarstedt AG, Nürnbrecht, Germany) in order to 
separate plasma from cells. Electrolytes, creatinine and urea were measured in urine and/or plasma samples using 
a Synchron DXC800 analyzer (Beckman Coulter, Fullerton, CA). Plasma and urine osmolality was determined on 
a multi-sample osmometer (Advanced Instruments Model 2020, Norwood, MA). Urine NGAL levels were meas-
ured using an enzyme-linked immunosorbent assay according to the manufacturer’s instructions (EMLCN2, 
Thermo Fischer Scientific, Waltham, MA). All tests were performed in The Jackson Laboratory, Bar Harbor, ME 
or the University of Zurich, Zurich, Switzerland according to protocols approved by The Jackson Laboratory’s 
Animal Care and Use Committee and the Swiss Cantonal Veterinary Authority (103/2014), respectively.
isolation, growth and treatment of mouse thick ascending limb cells. Thick ascending limbs 
from 6- to 8-weeks old male C57BL/6J-HpnHlb320/Hlb320 or C57BL/6J-HpnWT/WT mice were isolated and cultured 
as reported previously19. Thick ascending limbs were manually collected under a light microscope and seeded on 
fibronectin-coated (Corning Inc., Corning, NY) 96-well plastic plates (Thermo Fischer Scientific) containing a 
culture medium based on DMEM:F1219 (Thermo Fischer Scientific) and placed in a humidified chamber at 37 °C 
and 5% CO2. When cellular outgrow reached near confluence, cells were passed using 0.05% Trypsin-EDTA 
(Thermo Fischer Scientific) to fibronectin and collagen-coated 0.33 cm2 PTFE filter membranes (Corning Inc., 
Corning, NY). After a confluent monolayer of cells was reached, supplemented FBS (Thermo Fischer Scientific) 
was reduced from 2% to 0.1% (v/v) to allow maximal differentiation. Cells were treated with 100 µM bumetanide 
(Sigma-Aldrich) to the apical side, with 0.1 µM ddAVP (Sigma-Aldrich) to the basolateral side or with 2.5 µg/
mL tunicamycin (Sigma-Aldrich) to the apical and basolateral side. Transepithelial voltage measurements were 
performed using chopstick electrodes (STX2, World precision instruments, Sarasota, FL) according to manufac-
turer’s instructions.
protein extraction, sample processing and immunoblotting. Mice were euthanized with a lethal 
dose of isoflurane (Minrad International Inc., Orchard Park, NY) and both kidneys were removed and decap-
sulated. One kidney was rapidly frozen in liquid nitrogen and grinded using a pestle and mortar. The other 
kidney was processed for immunohistochemistry and mRNA analysis. Proteins were extracted from grinded 
tissue or mTAL cells using ice-cold RIPA buffer (Sigma-Aldrich, St.-Louis, MO) with the addition of protease 
and phosphatase inhibitors (Roche, Basel, Switzerland), followed by a centrifugation for 15 min at 1000 g and 4 °C 
to remove debris and a brief sonication of the supernatant. When required, proteins were extracted in a sucrose 
buffer (1 mM EDTA, 20 mM Imidazole and 250 mM Sucrose, pH 7.2) and pellets enriched in large plasma mem-
branes (“membrane fraction”) (17,000 g, 1 h, 4 °C) and in cytoplasmic proteins and cytoplasmic vesicles (“cyto-
solic fraction”) (200,000 g, 2 h, 4 °C) were sequentially collected. Proteins from urine samples or from apical cell 
medium were N-deglycosylated using PNGaseF (New England Biolabs, Ipswich, MA) according to manufactur-
er’s instructions. Polymerization assay on urinary samples was performed as previously described. In brief, urine 
samples were centrifuged at 150,000 g for 3 h at 20 °C. The supernatants were removed and the pellets solubilized 
in SDS sample buffer for downstream analysis15. Protein concentration was assessed using the bicinchoninic 
acid (BCA) protein assay kit (Thermo Fischer Scientific) and urine sample loading was normalized to creatinine 
content. Urine samples, cell medium and tissue or cell lysates were mixed with Laemmli sample buffer (Bio Rad 
Laboratories, Hercules, CA), proteins were separated on 7.5–12% SDS-PAGE gel in non-reducing (uromodulin) 
or in reducing (all other analyses) conditions and transferred onto PVDF membrane (Bio Rad). Western blotting 
was performed using established protocols19. Densitometric quantification was done with the ImageJ software35.
1 2Scientific RepoRtS |         (2019) 9:12287  | https://doi.org/10.1038/s41598-019-48300-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Histological analysis and immunostaining. Half kidneys were fixed in 4% formaldehyde 
(Sigma-Aldrich) and embedded in paraffin. Paraffin blocks were cut into 5-µm-thick sections, deparaffinated 
in xylene and re-hydrated in serial ethanol concentrations. Periodic acid-Schiff staining was performed accord-
ing to standard protocols and images were captured with a light microscope. For immunofluorescence analysis, 
epitope retrieval was performed in a 10 mM citric acid solution (pH 6.0) at 98 °C for 10 min in a tissue processor 
(Milestone Inc., Shelton, CT). Sections were then blocked in PBS containing 3% BSA (Sigma-Aldrich), 30 mM gly-
cine (Sigma-Aldrich), 50 mM NH4Cl (VWR international, Radnor, PA) and 0.05% Tween-20 (Merck-Millipore) 
for 1 hour at room temperature. The samples were incubated with the primary antibody for 2 hours in a humid-
ified chamber at RT or overnight at 4 °C and subsequently with the appropriate AlexaFluor-labeled secondary 
antibody (1:300, Life Technologies, Carlsbad, CA) for 1 hour at RT. Where appropriate, a second primary anti-
body and its secondary antibody were applied. TAL monolayers on PTFE filters were fixed for 10 minutes in 2% 
formaldehyde (Sigma-Aldrich), permeabilized for 30 minutes using 0.5% saponin (Sigma-Aldrich) and blocked 
overnight at 4 °C in 3% BSA (Sigma-Aldrich). The immune-staining procedures were then similar to the kidney 
sections. After the last washing step, filters were cut onto a glass slide. Kidney sections and filters were mounted 
in Prolong Gold Anti-fade reagent containing DAPI (Invitrogen Corp., Waltham, MA) and viewed under a con-
focal microscope (Leica Microsystems GmbH, Wetzlar, Germany) using a ×63 1.4 NA oil immersion objective. 
Acquisition parameters were kept identical for the same antibody in different kidney sections. Image processing, 
quantification of uromodulin polymers/field, relative polymer size and % of field area covered by polymers is 
performed using ImageJ software and ImageJ Ridge detection35.
Antibodies. The following antibodies were used: sheep anti-uromodulin (K90071C, Meridien Life Science 
Inc., Cincinnati, OH; 1:500 for WB and 1:300 for IF), sheep-anti uromodulin (ab9029, Abcam; 1:500 for WB), 
rabbit anti-hepsin (100022, Cayman Chemical, Ann Arbor, MI; 1:50 for IF), mouse anti-flotillin-1 (BD 610821, BD 
Biosciences, Franklin Lakes, NJ, 1:500 for WB), rabbit anti-GAPDH (2118, Cell Signaling Technology, Danvers, 
MA; 1:500 for WB), mouse anti-βactin (A5441, Sigma-Aldrich; 1:10 000 for WB), rabbit anti-calnexin (C4731, 
Sigma-Aldrich; 1:300 for IF), rabbit anti-phospho NKCC2 (R5, phosphorylated Thr96 and Thr101)(gift from 
Prof. Biff Forbusch, Yale; 1:500 for WB), rabbit anti-phospho NKCC2 (phosphorylated Thr96) (gift from Prof. Jan 
Loffing, Zurich; 1:300 for IF), rabbit anti-NKCC2 (AB3562P, Merck-Millipore, 1:500 for WB and 1:100 for IF), 
rabbit anti-phospho NCC (phosphorylated Thr53)(gift from Prof. Jan Loffing; 1:5000 for WB), rabbit anti-NCC 
(AB3553, Merck-Millipore, 1:500 for WB), rabbit anti-aquaporin 1 (AB2219, Merck Millipore; 1:500 for WB), 
rabbit anti-aquaporin 2 (A7310, Sigma-Aldrich; 1:1000 for WB), anti-phospho SPAK (Ser373)/phospho OSR1 
(Ser325)(07–2273, Merck Millipore; 1:500 for WB and 1:300 for IF), rabbit anti-SPAK (07–2271, Merck Millipore; 
1:500 for WB), mouse anti-GM130 (ab169276, Abcam, Cambridge, UK; 1:300 for IF), rabbit anti-NGAL (ab63929, 
Abcam; 1:500 for WB), rabbit anti-GRP78 (ab21685, Abcam; 1:500 for WB and 1:300 for IF).
Determination of oxygen consumption rate. Oxygen consumption rate (OCR) was measured in 
freshly microdissected TAL tubules using the XFp Extracellular Flux Analyzer and the XFp Cell Mito Stress Test 
kit (Seahorse Bioscience, North Billerica, MA). TAL microdissection was performed as described above with 
following modifications: TAL’s were collected in XF-Base Medium supplemented with 2 mM L-glutamine, 1 mM 
sodium pyruvate and 10 mM glucose (pH 7.4) and seeded in the Seahorse XFp Cell Culture Miniplate containing 
the same medium and kept for 1 h at 37 °C in ambient air. OCR was measured at basal condition and following the 
injection of bumetanide (Sigma-Aldrich) at a final concentration of 100 µM. After the measurement, tubules were 
fixed in 4% PFA and tubule length was assessed using ImageJ software35.
Tail cuff manometry. Systolic blood pressure (SBP) was assessed by a non-invasive computerized tail cuff 
method (Visitech Systems, Apex, NC) as described36. Animals were trained for 5 days before the start of the study. 
SBP was measured following a fixed daily schedule. Multiple consecutive recordings (at least 10) were performed 
for each animal and then averaged in order to get a SBP of the day. Daily SBP averages were only considered for 
the final analysis if standard deviations of the individual recordings were below 10 mmHg. SBP were measured 
this way during at least 3 consecutive days, measurements were then again averaged for each mouse for the 
reporting period (reporting periods last between 3 and 5 days). SBP reporting periods included a baseline period 
as well as reporting periods starting 1 week, 1 month and 2 months after the 2% oral NaCl loading protocol 
started.
induction of urinary tract infections. Transurethral instillation of uropathogenic E. coli was performed as 
described37. In brief, human UPEC strain J96 (ATCC 700336) was statically grown in LB broth at 37 °C with serial 
passages to ensure type-1 pili expression. Bacteria were resuspended in PBS and their viable concentration was 
determined by titration on LB agar plates. 1.65 × 108 CFU in 50 µL were transurethrally instilled in the bladders 
of 10 week-old female Hlb320 and WT mice. Animals were euthanized 24 h after UPEC instillation, bladders 
were aseptically removed, homogenized and remaining CFU were determined by LB agar microtiter dilution. The 
importance of bacterial pili for bladder colonization was verified using a strain of FimH-deficient E. coli (W3110) 
(not shown, kindly provided by Prof. Glockshuber, ETH).
RnA extraction, reverse transcription, pcR, quantitative pcR. Analysis of gene expression levels 
in mouse kidneys and TAL cells were performed based on the MIQUE guidelines38. In brief, the extraction of 
total RNA from TAL cells was performed using RNAqueous-Micro kit (Ambion, Huntingdon, UK). Total RNA 
was extracted from kidney using AurumTM Total RNA Fatty and Fibrous Tissue Kit (Bio Rad, Hercules, CA), 
following the protocol of the manufacturer. Contamination by genomic DNA was eliminated by DNAse I treat-
ment. Reverse transcriptase reaction with iScriptTM cDNA Synthesis Kit (Bio Rad) was executed with up to1 µg of 
RNA. When needed, PCR products were size-fractionated on 1.5% agarose gel and stained with EZ-VisionR One 
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(AMRESCO, Solon, OH). The variations in mRNA levels of the target genes were established by relative RT-qPCR 
with a CFX96TM Real-Time PCR Detection System (Bio Rad) and the iQTM SYBR Green Supermix (Bio Rad) for 
the detection of single PCR product accumulation. 100 nM of sense and anti-sense primers were used in a final 
volume of 20 µl in iQTM SYBR Green Supermix (Bio Rad) to perform RT-qPCR analyses (in duplicate). Primers 
specific to targets were designed with Primer339 (Suppl. Table S1). PCR conditions were: 95 °C, 3 min followed 
by 40 cycles of 15 sec, 95 °C and 30 seconds at 60 °C. The efficiency of each set of primers was determined by 
dilution curves (Suppl. Table S1). For TAL cell expression studies, Gapdh was used as a reference gene. In order 
to characterize the expression stability of the candidate reference genes in kidney, the program geNorm version 
3.4 was applied. The most stable genes are stepwise selected from the investigated gene panel and a common 
Normalization Factor (NF) can be calculated for the genes selected for the normalization procedure. We selected 
the 6 tested reference genes to calculate the Normalization Factor40.
Silencing of hepsin expression. Hepsin shRNAs (Santa Cruz Biotechnologies, Dallas, TX) is a pool of 
concentrated, transduction-ready lentiviral particles containing 3 target-specific constructs that encode 19–25 nt 
(plus hairpin) shRNA designed to knock down Hpn gene expression. The transduction was performed at a con-
centration of 3.3 × 105 and 6.6 × 105 pfu/ml. Briefly, primary mouse TAL cells were seeded onto collagen-coated 
filters (Corning Inc., Corning, NY) and lentivirus infections were performed 24 h after plating at around 70% of 
confluence with 5 µg/ml of polybrene. Cells were incubated for 12 h at 37 °C with culture medium containing the 
virus, then changed with 0.1% FBS culture medium for other 5 days. Control cells were transduced in parallel 
with a control shRNA Lentiviral Particles-A (Santa Cruz Biotechnologies).
Sanger sequencing. Sequencing of the PCR products was done with the BigDye terminator kit (Perkin 
Elmer, Waltham, MA). A dye-terminator removal process was performed with the multiScreen SEQ384. Filter 
Plate (Merck-Millipore, Billerica, MA) and Sephadex G-50 DNA Grade Fine (Amersham, Buckinghamshire, UK) 
to purify the sequences reactions which were next analysed with an ABI3100 capillary sequencer (Perkin Elmer).
Statistical analysis. Values are expressed as arithmetic mean ± standard error of the mean (s.e.m.). 
Statistical comparisons were performed using an unpaired two-tailed Student’s t test (GraphPad Software, La 
Jolla CA) or a paired two-tailed Student’s t test (GraphPad Software, La Jolla CA). P values ≤ 0.05 were considered 
as statistically significant.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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